154 related articles for article (PubMed ID: 36092973)
1. An evaluation of race-based representation among men participating in clinical trials for prostate cancer and erectile dysfunction.
Saltzman RG; Zucker I; Campbell K; Gandhi DA; Otiono K; Weber A; Masterson TA; Ramasamy R
Contemp Clin Trials Commun; 2022 Oct; 29():100986. PubMed ID: 36092973
[TBL] [Abstract][Full Text] [Related]
2. Exploring representation of underrepresented minority men in a restorative therapy clinical trial for erectile dysfunction: addressing barriers and promoting inclusion.
Ledesma BR; Thomas J; Ghomeshi A; Saltzman RG; Almatari A; White J; Arbelaez MCS; Ramasamy R
Int J Impot Res; 2023 Jul; ():. PubMed ID: 37516799
[TBL] [Abstract][Full Text] [Related]
3. Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics.
Varma T; Wallach JD; Miller JE; Schnabel D; Skydel JJ; Zhang AD; Dinan MA; Ross JS; Gross CP
JAMA Netw Open; 2021 Apr; 4(4):e217063. PubMed ID: 33877309
[TBL] [Abstract][Full Text] [Related]
4. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.
Allison K; Patel DG; Greene L
JAMA Netw Open; 2021 May; 4(5):e218348. PubMed ID: 34003274
[TBL] [Abstract][Full Text] [Related]
5. Increasing diversity in clinical trials: Demographic trends at the national cancer institute, 2005-2020.
Choradia N; Karzai F; Nipp R; Naqash AR; Gulley JL; Floudas CS
J Natl Cancer Inst; 2024 Feb; ():. PubMed ID: 38374401
[TBL] [Abstract][Full Text] [Related]
6. Representation of Women and Minorities in Clinical Trials for New Molecular Entities and Original Therapeutic Biologics Approved by FDA CDER from 2013 to 2015.
Chen A; Wright H; Itana H; Elahi M; Igun A; Soon G; Pariser AR; Fadiran EO
J Womens Health (Larchmt); 2018 Apr; 27(4):418-429. PubMed ID: 29048983
[TBL] [Abstract][Full Text] [Related]
7. Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018.
Loree JM; Anand S; Dasari A; Unger JM; Gothwal A; Ellis LM; Varadhachary G; Kopetz S; Overman MJ; Raghav K
JAMA Oncol; 2019 Oct; 5(10):e191870. PubMed ID: 31415071
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of trends in the representation of patients by age, sex, and diverse race/ethnic groups in bladder and kidney cancer clinical trials.
Javier-DesLoges J; Nelson TJ; Murphy JD; McKay RR; Stewart TF; Kader AK; Derweesh I; Martinez ME; Rose BS
Urol Oncol; 2022 May; 40(5):199.e15-199.e21. PubMed ID: 35431133
[TBL] [Abstract][Full Text] [Related]
9. Racial, Ethnic, and Gender Representation in Leadership Positions at National Cancer Institute-Designated Cancer Centers.
Morgan A; Shah K; Tran K; Chino F
JAMA Netw Open; 2021 Jun; 4(6):e2112807. PubMed ID: 34097046
[TBL] [Abstract][Full Text] [Related]
10. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials.
Javier-DesLoges J; Nelson TJ; Murphy JD; McKay RR; Pan E; Parsons JK; Kane CJ; Kader AK; Derweesh IH; Nodora J; Patel SP; Martinez ME; Rose BS
Cancer; 2022 Feb; 128(4):770-777. PubMed ID: 34806168
[TBL] [Abstract][Full Text] [Related]
11. Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies.
Aldrighetti CM; Niemierko A; Van Allen E; Willers H; Kamran SC
JAMA Netw Open; 2021 Nov; 4(11):e2133205. PubMed ID: 34748007
[TBL] [Abstract][Full Text] [Related]
12. Demographic representation in clinical trials for cell-based therapy.
Saltzman RG; Jayaweera DT; Caceres LV; Tovar JA; Vidro-Casiano M; Karakeshishyan V; Soto J; Khan A; Mitrani RD; Schulman IH; Hare JM
Contemp Clin Trials Commun; 2021 Mar; 21():100702. PubMed ID: 33511300
[TBL] [Abstract][Full Text] [Related]
13. Minority Enrollment in Phase II and III Clinical Trials in Urologic Oncology.
Owens-Walton J; Williams C; Rompré-Brodeur A; Pinto PA; Ball MW
J Clin Oncol; 2022 May; 40(14):1583-1589. PubMed ID: 35196107
[TBL] [Abstract][Full Text] [Related]
14. Racial disparities in erectile dysfunction among participants in the California Men's Health Study.
Smith JF; Caan BJ; Sternfeld B; Haque R; Quesenberry CP; Quinn VP; Shan J; Walsh TJ; Lue TF; Jacobsen SJ; Van den Eeden SK
J Sex Med; 2009 Dec; 6(12):3433-9. PubMed ID: 19796017
[TBL] [Abstract][Full Text] [Related]
15. Racial and Ethnic Diversity in Janus Kinase Inhibitor Alopecia Areata Clinical Trials: A Systematic Review.
Ezemma O; Devjani S; Jothishankar B; Kelley KJ; Senna M
Skin Appendage Disord; 2023 Oct; 9(5):351-354. PubMed ID: 37900778
[TBL] [Abstract][Full Text] [Related]
16. A Cross-Sectional Study of Sex, Race, and Ethnic Representation in Burn Registered Clinical Trials.
Sheikh-Oleslami S; Tao B; Papp B; Luthra S; Papp A
J Racial Ethn Health Disparities; 2023 Dec; ():. PubMed ID: 38148442
[TBL] [Abstract][Full Text] [Related]
17. Sex, Racial, and Ethnic Disparities in U.S. Cardiovascular Trials in More Than 230,000 Patients.
Preventza O; Critsinelis A; Simpson K; Olive JK; LeMaire SA; Cornwell LD; Jimenez E; Byrne J; Chatterjee S; Rosengart TK; Coselli JS
Ann Thorac Surg; 2021 Sep; 112(3):726-735. PubMed ID: 33189670
[TBL] [Abstract][Full Text] [Related]
18. Erectile dysfunction, masculinity, and psychosocial outcomes: a review of the experiences of men after prostate cancer treatment.
Chambers SK; Chung E; Wittert G; Hyde MK
Transl Androl Urol; 2017 Feb; 6(1):60-68. PubMed ID: 28217451
[TBL] [Abstract][Full Text] [Related]
19. Racial/Ethnic Disparities in Ophthalmology Clinical Trials Resulting in US Food and Drug Administration Drug Approvals From 2000 to 2020.
Berkowitz ST; Groth SL; Gangaputra S; Patel S
JAMA Ophthalmol; 2021 Jun; 139(6):629-637. PubMed ID: 33885724
[TBL] [Abstract][Full Text] [Related]
20. Racial and Ethnic Disparities in European Breast Cancer Clinical Trials.
Bania A; Adamou A; Saloustros E
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
